McKesson Europe AG (LTS:0OPB) Cash And Cash Equivalents : €5 Mil (As of Mar. 2022)

View and export this data going back to 2010. Start your Free Trial

What is McKesson Europe AG Cash And Cash Equivalents?

McKesson Europe AG's quarterly cash and cash equivalents declined from Mar. 2020 (€970.20 Mil) to Mar. 2021 (€189.80 Mil) but then stayed the same from Mar. 2021 (€189.80 Mil) to Mar. 2022 (€5.30 Mil).

McKesson Europe AG's annual cash and cash equivalents declined from Mar. 2020 (€970.20 Mil) to Mar. 2021 (€189.80 Mil) and declined from Mar. 2021 (€189.80 Mil) to Mar. 2022 (€5.30 Mil).

McKesson Europe AG Cash And Cash Equivalents Historical Data

The historical data trend for McKesson Europe AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Cash And Cash Equivalents Chart

McKesson Europe AG Annual Data

Trend

Dec12

Dec13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Cash And Cash Equivalents

Get a 7-Day Free Trial

796.40

826.80

970.20

189.80

5.30

McKesson Europe AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
Cash And Cash Equivalents	Get a 7-Day Free Trial															796.40	826.80	970.20	189.80	5.30

McKesson Europe AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

McKesson Europe AG (LTS:0OPB) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

McKesson Europe AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson Europe AG (LTS:0OPB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (LTS:0OPB) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Stockholmer Platz 1, Stuttgart, BW, DEU, 70137

Website

https://www.mckesson.eu

McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (LTS:0OPB) Headlines

No Headlines